ArticleJournal of stroke2025

Switch to Rosuvastatin Plus Ezetimibe From Statin Monotherapy to Achieve Target LDL-Cholesterol Goal: A Multi-Center, Open-Label, Single-Arm Trial.

Hong-Kyun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.